D86.0 ICD-10-CM Code: Sarcoidosis of lung
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) / Certain disorders involving the immune mechanism (D80-D89)
D86.0
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceSarcoidosis of lung
Sarcoidosis is an inflammatory disease where abnormal tissue collections form in the lungs, causing breathing problems and chest discomfort.

Buddy Insight
Sarcoidosis of lung is a chronic granulomatous disease of unknown etiology characterized by non-caseating granulomas in the pulmonary parenchyma and hilar lymph nodes.
CMS-HCC V28
00
RAF 0
CMS-HCC V24
MappedHCC 112
RAF 0.268
ACA/HHS
00
RAF 0
ESRD/PACE
MappedHCC 112
RAF 0.0
RXHCC
MappedHCC 227
RAF 0.0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
OfficialICD-10-CM does not list inclusion terms for D86.0 in this effective period.
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for D86.0 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for D86.0 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for D86.0 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for D86.0 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for D86.0 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for D86.0 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is D86.0 an HCC code?
Yes. D86.0 maps to Fibrosis of Lung and Other Chronic Lung Disorders under the V24 model but is not retained in V28.
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for D86.0
For D86.0to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed D86.0 during that encounter, not just copy-forwarded from a problem list.
What This Code Means
D86.0 is the ICD-10-CM diagnosis code for sarcoidosis of lung. Sarcoidosis is an inflammatory disease where abnormal tissue collections form in the lungs, causing breathing problems and chest discomfort. D86.0 sits in the ICD-10-CM chapter for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (d50-d89), within the section covering certain disorders involving the immune mechanism (d80-d89).
Under the older CMS-HCC V24 model, D86.0 maps to Fibrosis of Lung and Other Chronic Lung Disorders (HCC 112) with a community, non-dual, aged base RAF weight of 0.268. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Specify the stage of pulmonary sarcoidosis if documented (0-IV). Because D86.0 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for D86.0 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Specify the stage of pulmonary sarcoidosis if documented (0-IV)
- •Code any associated respiratory complications separately (e.g., pulmonary fibrosis)
Clinical Significance
Sarcoidosis of lung is a chronic granulomatous disease of unknown etiology characterized by non-caseating granulomas in the pulmonary parenchyma and hilar lymph nodes. It most commonly affects young adults, with higher prevalence in African Americans and Northern Europeans, and can range from asymptomatic bilateral hilar lymphadenopathy to progressive pulmonary fibrosis with respiratory failure.
Documentation Requirements
- ✓Documentation must include radiographic staging (stage 0-IV based on chest imaging), pulmonary function test results, histological confirmation of non-caseating granulomas when available, symptom severity, and current treatment including corticosteroids or steroidsparing agents if prescribed.
- ✓Specify whether the disease is active, stable, or progressive, and document any pulmonary complications such as pulmonary hypertension or fibrosis.
Commonly Confused Codes
- •D86.1 (sarcoidosis of lymph nodes which may coexist with but is distinct from pulmonary parenchymal disease), D86.2 (sarcoidosis of lung with sarcoidosis of lymph nodes when both are present), J84.10 (pulmonary fibrosis, unspecified, which may be a sequela of sarcoidosis), D86.9 (sarcoidosis, unspecified, when the organ involvement is not documented).